Zenotech Laboratories Ltd

Zenotech Laboratories Ltd (ZENOTECH) is a micro-cap Healthcare company valued at ₹262 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Zenotech Laboratories Ltd last traded at ₹42.89, modestly down 0.39% on the day.

Recent developments

On 2026-06-30, the company reported a net loss of ₹1 crore for the latest financial year, marking a sharp decline from the prior year's profit of ₹6 crore. In the latest quarter, net profit turned to a loss of ₹0 crore, contrasting with a profit of ₹1 crore in the same quarter a year earlier.

Financial performance

The company's business is shrinking, with annual revenue rising just 1.5% to ₹40 crore, but net profit swung to a loss of ₹1 crore from a profit of ₹6 crore. The latest quarter showed a loss of ₹0 crore, down from a profit of ₹1 crore a year earlier, while revenue rose 11.1% to ₹10 crore.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 2.87 times book value.

Things to watch

The company's net profit margin has plunged to -2.7%, down 17.1 percentage points from 14.4% a year ago. Net profit swung to a loss of ₹1 crore in the latest financial year, and the latest quarter also ended in a loss of ₹0 crore. The stock is 16.9% below its 52-week high.

Where it stands

Zenotech Laboratories Ltd ended the latest quarter with a net loss of ₹0 crore, while annual net profit swung to a loss of ₹1 crore. The stock is 16.9% below its 52-week high, and the net profit margin has dropped to -2.7%.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.